Canopy Growth is a cannabis company that cultivates, processes, and sells recreational and medical cannabis products, including flower, extracts, and consumer brands. It operates primarily in regulated markets, with a significant footprint in Canada and selected international medical channels. The business model combines production capacity with branded finished goods sold through licensed retailers and medical distribution.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 72.1 | — | -44.9 | — |
| Q3 2025 | 66.7 | — | -1.6 | — |
| Q4 2025 | 74.5 | — | -62.6 | — |
| Q1 2026 | 71.3 | — | -157.1 | — |
| Q2 2026 | 81.2 | 12.5% | -14.6 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: NN, Inc. (NNBR), Irenic Acquisition Corp. (IACQ), Opus Genetics, Inc. (IRD), Forafric Global PLC (AFRI), Range Capital Acquisition Corp II (RNGT), Cantor Equity Partners VII, Inc. (CAES)